Pleurodynia Treatment Market Size, Share, Trends, Growth 2030
Pleurodynia Treatment Market By Causes (Coxsackievirus B, Coxsackievirus A, and Echovirus), By Complications (Meningitis, Tachycardia, Hepatitis, Pericarditis, Myocarditis, and Orchitis)), By Symptoms (Chest Pain, Cough, Fever, Sore Throat, Headache, and Muscular Aches & Pains), and By Region - Global and Regional Industry Overview, Market Intelligence, Comprehensive Analysis, Historical Data, and Forecasts 2023 - 2030
Category: Healthcare Report Format : PDF
Pages: 199 Report Code: ZMR-7149
Published Date: Apr-2023 Status : Published
| Market Size in 2022 | Market Forecast in 2030 | CAGR (in %) | Base Year |
|---|---|---|---|
| USD 128.57 Million | USD 191.58 Million | 5.28% | 2022 |
Table Of Content
- Chapter 1. Preface
- 1.1 Report Description and Scope
- 1.2 Research scope
- 1.3 Research methodology
- 1.3.1 Market Research Type
- 1.3.2 Market research methodology
- Chapter 2. Executive Summary
- 2.1 Global Pleurodynia Treatment Market, (2023 - 2030) (USD Million)
- 2.2 Global Pleurodynia Treatment Market : snapshot
- Chapter 3. Global Pleurodynia Treatment Market - Industry Analysis
- 3.1 Pleurodynia Treatment Market: Market Dynamics
- 3.2 Market Drivers
- 3.2.1 Growing prevalence of the condition to propel market growth
- 3.3 Market Restraints
- 3.3.1. Absence of concrete diagnosis to restrict market expansion
- 3.4 Market Opportunities
- 3.4.1. Growing investment toward novel therapies to prove growth opportunities
- 3.5 Market Challenges
- 3.5.1. Regulatory challenges to restrict market expansion
- 3.6 Porter’s Five Forces Analysis
- 3.7 Market Attractiveness Analysis
- 3.7.1 Market attractiveness analysis By Causes
- 3.7.2 Market attractiveness analysis By Complications
- 3.7.3 Market attractiveness analysis By Symptoms
- Chapter 4. Global Pleurodynia Treatment Market- Competitive Landscape
- 4.1 Company market share analysis
- 4.1.1 Global Pleurodynia Treatment Market: company market share, 2022
- 4.2 Strategic development
- 4.2.1 Acquisitions & mergers
- 4.2.2 New Product launches
- 4.2.3 Agreements, partnerships, cullaborations, and joint ventures
- 4.2.4 Research and development and Regional expansion
- 4.3 Price trend analysis
- 4.1 Company market share analysis
- Chapter 5. Global Pleurodynia Treatment Market - Causes Analysis
- 5.1 Global Pleurodynia Treatment Market overview: By Causes
- 5.1.1 Global Pleurodynia Treatment Market share, By Causes, 2022 and 2030
- 5.2 Coxsackievirus B
- 5.2.1 Global Pleurodynia Treatment Market by Coxsackievirus B, 2023 - 2030 (USD Million)
- 5.3 Coxsackievirus A
- 5.3.1 Global Pleurodynia Treatment Market by Coxsackievirus A, 2023 - 2030 (USD Million)
- 5.4 Echovirus
- 5.4.1 Global Pleurodynia Treatment Market by Echovirus, 2023 - 2030 (USD Million)
- 5.1 Global Pleurodynia Treatment Market overview: By Causes
- Chapter 6. Global Pleurodynia Treatment Market - Complications Analysis
- 6.1 Global Pleurodynia Treatment Market overview: By Complications
- 6.1.1 Global Pleurodynia Treatment Market share, By Complications, 2022 and 2030
- 6.2 Meningitis
- 6.2.1 Global Pleurodynia Treatment Market by Meningitis, 2023 - 2030 (USD Million)
- 6.3 Tachycardia
- 6.3.1 Global Pleurodynia Treatment Market by Tachycardia, 2023 - 2030 (USD Million)
- 6.4 Hepatitis
- 6.4.1 Global Pleurodynia Treatment Market by Hepatitis, 2023 - 2030 (USD Million)
- 6.5 Pericarditis
- 6.5.1 Global Pleurodynia Treatment Market by Pericarditis, 2023 - 2030 (USD Million)
- 6.6 Myocarditis
- 6.6.1 Global Pleurodynia Treatment Market by Myocarditis, 2023 - 2030 (USD Million)
- 6.7 Orchitis
- 6.7.1 Global Pleurodynia Treatment Market by Orchitis, 2023 - 2030 (USD Million)
- 6.1 Global Pleurodynia Treatment Market overview: By Complications
- Chapter 7. Global Pleurodynia Treatment Market - Symptoms Analysis
- 7.1 Global Pleurodynia Treatment Market overview: By Symptoms
- 7.1.1 Global Pleurodynia Treatment Market share, By Symptoms, 2022 and 2030
- 7.2 Chest Pain
- 7.2.1 Global Pleurodynia Treatment Market by Chest Pain, 2023 - 2030 (USD Million)
- 7.3 Cough
- 7.3.1 Global Pleurodynia Treatment Market by Cough, 2023 - 2030 (USD Million)
- 7.4 Fever
- 7.4.1 Global Pleurodynia Treatment Market by Fever, 2023 - 2030 (USD Million)
- 7.5 Sore Throat
- 7.5.1 Global Pleurodynia Treatment Market by Sore Throat, 2023 - 2030 (USD Million)
- 7.6 Headache
- 7.6.1 Global Pleurodynia Treatment Market by Headache, 2023 - 2030 (USD Million)
- 7.7 Muscular Aches & Pains
- 7.7.1 Global Pleurodynia Treatment Market by Muscular Aches & Pains, 2023 - 2030 (USD Million)
- 7.1 Global Pleurodynia Treatment Market overview: By Symptoms
- Chapter 8. Pleurodynia Treatment Market - Regional Analysis
- 8.1 Global Pleurodynia Treatment Market Regional Overview
- 8.2 Global Pleurodynia Treatment Market Share, by Region, 2022 & 2030 (USD Million)
- 8.3. North America
- 8.3.1 North America Pleurodynia Treatment Market, 2023 - 2030 (USD Million)
- 8.3.1.1 North America Pleurodynia Treatment Market, by Country, 2023 - 2030 (USD Million)
- 8.3.1 North America Pleurodynia Treatment Market, 2023 - 2030 (USD Million)
- 8.4 North America Pleurodynia Treatment Market, by Causes, 2023 - 2030
- 8.4.1 North America Pleurodynia Treatment Market, by Causes, 2023 - 2030 (USD Million)
- 8.5 North America Pleurodynia Treatment Market, by Complications, 2023 - 2030
- 8.5.1 North America Pleurodynia Treatment Market, by Complications, 2023 - 2030 (USD Million)
- 8.6 North America Pleurodynia Treatment Market, by Symptoms, 2023 - 2030
- 8.6.1 North America Pleurodynia Treatment Market, by Symptoms, 2023 - 2030 (USD Million)
- 8.4. Europe
- 8.4.2 Europe Pleurodynia Treatment Market, 2023 - 2030 (USD Million)
- 8.4.2.1 Europe Pleurodynia Treatment Market, by Country, 2023 - 2030 (USD Million)
- 8.4.2 Europe Pleurodynia Treatment Market, 2023 - 2030 (USD Million)
- 8.4 Europe Pleurodynia Treatment Market, by Causes, 2023 - 2030
- 8.4.1 Europe Pleurodynia Treatment Market, by Causes, 2023 - 2030 (USD Million)
- 8.5 Europe Pleurodynia Treatment Market, by Complications, 2023 - 2030
- 8.5.1 Europe Pleurodynia Treatment Market, by Complications, 2023 - 2030 (USD Million)
- 8.6 Europe Pleurodynia Treatment Market, by Symptoms, 2023 - 2030
- 8.6.1 Europe Pleurodynia Treatment Market, by Symptoms, 2023 - 2030 (USD Million)
- 8.5. Asia Pacific
- 8.5.3 Asia Pacific Pleurodynia Treatment Market, 2023 - 2030 (USD Million)
- 8.5.3.1 Asia Pacific Pleurodynia Treatment Market, by Country, 2023 - 2030 (USD Million)
- 8.5.3 Asia Pacific Pleurodynia Treatment Market, 2023 - 2030 (USD Million)
- 8.4 Asia Pacific Pleurodynia Treatment Market, by Causes, 2023 - 2030
- 8.4.1 Asia Pacific Pleurodynia Treatment Market, by Causes, 2023 - 2030 (USD Million)
- 8.5 Asia Pacific Pleurodynia Treatment Market, by Complications, 2023 - 2030
- 8.5.1 Asia Pacific Pleurodynia Treatment Market, by Complications, 2023 - 2030 (USD Million)
- 8.6 Asia Pacific Pleurodynia Treatment Market, by Symptoms, 2023 - 2030
- 8.6.1 Asia Pacific Pleurodynia Treatment Market, by Symptoms, 2023 - 2030 (USD Million)
- 8.6. Latin America
- 8.6.4 Latin America Pleurodynia Treatment Market, 2023 - 2030 (USD Million)
- 8.6.4.1 Latin America Pleurodynia Treatment Market, by Country, 2023 - 2030 (USD Million)
- 8.6.4 Latin America Pleurodynia Treatment Market, 2023 - 2030 (USD Million)
- 8.4 Latin America Pleurodynia Treatment Market, by Causes, 2023 - 2030
- 8.4.1 Latin America Pleurodynia Treatment Market, by Causes, 2023 - 2030 (USD Million)
- 8.5 Latin America Pleurodynia Treatment Market, by Complications, 2023 - 2030
- 8.5.1 Latin America Pleurodynia Treatment Market, by Complications, 2023 - 2030 (USD Million)
- 8.6 Latin America Pleurodynia Treatment Market, by Symptoms, 2023 - 2030
- 8.6.1 Latin America Pleurodynia Treatment Market, by Symptoms, 2023 - 2030 (USD Million)
- 8.7. The Middle-East and Africa
- 8.7.5 The Middle-East and Africa Pleurodynia Treatment Market, 2023 - 2030 (USD Million)
- 8.7.5.1 The Middle-East and Africa Pleurodynia Treatment Market, by Country, 2023 - 2030 (USD Million)
- 8.7.5 The Middle-East and Africa Pleurodynia Treatment Market, 2023 - 2030 (USD Million)
- 8.4 The Middle-East and Africa Pleurodynia Treatment Market, by Causes, 2023 - 2030
- 8.4.1 The Middle-East and Africa Pleurodynia Treatment Market, by Causes, 2023 - 2030 (USD Million)
- 8.5 The Middle-East and Africa Pleurodynia Treatment Market, by Complications, 2023 - 2030
- 8.5.1 The Middle-East and Africa Pleurodynia Treatment Market, by Complications, 2023 - 2030 (USD Million)
- 8.6 The Middle-East and Africa Pleurodynia Treatment Market, by Symptoms, 2023 - 2030
- 8.6.1 The Middle-East and Africa Pleurodynia Treatment Market, by Symptoms, 2023 - 2030 (USD Million)
- Chapter 9. Company Profiles
- 9.1 Roche Holding AG
- 9.1.1 Overview
- 9.1.2 Financials
- 9.1.3 Product Portfolio
- 9.1.4 Business Strategy
- 9.1.5 Recent Developments
- 9.2 Gilead Sciences
- 9.2.1 Overview
- 9.2.2 Financials
- 9.2.3 Product Portfolio
- 9.2.4 Business Strategy
- 9.2.5 Recent Developments
- 9.3 AbbVie
- 9.3.1 Overview
- 9.3.2 Financials
- 9.3.3 Product Portfolio
- 9.3.4 Business Strategy
- 9.3.5 Recent Developments
- 9.4 GlaxoSmithKline
- 9.4.1 Overview
- 9.4.2 Financials
- 9.4.3 Product Portfolio
- 9.4.4 Business Strategy
- 9.4.5 Recent Developments
- 9.5 Bristol Myers Squibb
- 9.5.1 Overview
- 9.5.2 Financials
- 9.5.3 Product Portfolio
- 9.5.4 Business Strategy
- 9.5.5 Recent Developments
- 9.6 Johnson & Johnson
- 9.6.1 Overview
- 9.6.2 Financials
- 9.6.3 Product Portfolio
- 9.6.4 Business Strategy
- 9.6.5 Recent Developments
- 9.7 Boehringer Ingelheim
- 9.7.1 Overview
- 9.7.2 Financials
- 9.7.3 Product Portfolio
- 9.7.4 Business Strategy
- 9.7.5 Recent Developments
- 9.8 Pfizer
- 9.8.1 Overview
- 9.8.2 Financials
- 9.8.3 Product Portfolio
- 9.8.4 Business Strategy
- 9.8.5 Recent Developments
- 9.9 Novartis
- 9.9.1 Overview
- 9.9.2 Financials
- 9.9.3 Product Portfolio
- 9.9.4 Business Strategy
- 9.9.5 Recent Developments
- 9.10 Takeda Pharmaceuticals
- 9.10.1 Overview
- 9.10.2 Financials
- 9.10.3 Product Portfolio
- 9.10.4 Business Strategy
- 9.10.5 Recent Developments
- 9.11 Merck & Co.
- 9.11.1 Overview
- 9.11.2 Financials
- 9.11.3 Product Portfolio
- 9.11.4 Business Strategy
- 9.11.5 Recent Developments
- 9.12 Bayer
- 9.12.1 Overview
- 9.12.2 Financials
- 9.12.3 Product Portfolio
- 9.12.4 Business Strategy
- 9.12.5 Recent Developments
- 9.13 Teva Pharmaceutical Industries
- 9.13.1 Overview
- 9.13.2 Financials
- 9.13.3 Product Portfolio
- 9.13.4 Business Strategy
- 9.13.5 Recent Developments
- 9.14 AstraZeneca
- 9.14.1 Overview
- 9.14.2 Financials
- 9.14.3 Product Portfolio
- 9.14.4 Business Strategy
- 9.14.5 Recent Developments
- 9.15 Amgen
- 9.15.1 Overview
- 9.15.2 Financials
- 9.15.3 Product Portfolio
- 9.15.4 Business Strategy
- 9.15.5 Recent Developments
- 9.16 Eli Lilly and Company
- 9.16.1 Overview
- 9.16.2 Financials
- 9.16.3 Product Portfolio
- 9.16.4 Business Strategy
- 9.16.5 Recent Developments
- 9.17 Sanofi
- 9.17.1 Overview
- 9.17.2 Financials
- 9.17.3 Product Portfolio
- 9.17.4 Business Strategy
- 9.17.5 Recent Developments
- 9.18 Daiichi Sankyo
- 9.18.1 Overview
- 9.18.2 Financials
- 9.18.3 Product Portfolio
- 9.18.4 Business Strategy
- 9.18.5 Recent Developments
- 9.19 Astellas Pharma.
- 9.19.1 Overview
- 9.19.2 Financials
- 9.19.3 Product Portfolio
- 9.19.4 Business Strategy
- 9.19.5 Recent Developments
- 9.1 Roche Holding AG
Table Of Figures
- 1. Market research Type
- 2. Market research methodology
- 3. Global Pleurodynia Treatment Market, 2023 - 2030 (USD Million)
- 4. Porter’s Five Forces Analysis
- 5. Global Pleurodynia Treatment Market attractiveness, By Causes
- 6. Global Pleurodynia Treatment Market attractiveness, By Complications
- 7. Global Pleurodynia Treatment Market attractiveness, By Symptoms
- 8. Global Pleurodynia Treatment Market share by Causes, 2023 and 2030 (USD Million)
- 9. Global Pleurodynia Treatment Market by Coxsackievirus B, 2023 - 2030 (USD Million)
- 10. Global Pleurodynia Treatment Market by Coxsackievirus A, 2023 - 2030 (USD Million)
- 11. Global Pleurodynia Treatment Market by Echovirus, 2023 - 2030 (USD Million)
- 12. Global Pleurodynia Treatment Market share by Complications, 2023 and 2030 (USD Million)
- 13. Global Pleurodynia Treatment Market by Meningitis, 2023 - 2030 (USD Million)
- 14. Global Pleurodynia Treatment Market by Tachycardia, 2023 - 2030 (USD Million)
- 15. Global Pleurodynia Treatment Market by Hepatitis, 2023 - 2030 (USD Million)
- 16. Global Pleurodynia Treatment Market by Pericarditis, 2023 - 2030 (USD Million)
- 17. Global Pleurodynia Treatment Market by Myocarditis, 2023 - 2030 (USD Million)
- 18. Global Pleurodynia Treatment Market by Orchitis, 2023 - 2030 (USD Million)
- 19. Global Pleurodynia Treatment Market share by Symptoms, 2023 and 2030 (USD Million)
- 20. Global Pleurodynia Treatment Market by Chest Pain, 2023 - 2030 (USD Million)
- 21. Global Pleurodynia Treatment Market by Cough, 2023 - 2030 (USD Million)
- 22. Global Pleurodynia Treatment Market by Fever, 2023 - 2030 (USD Million)
- 23. Global Pleurodynia Treatment Market by Sore Throat, 2023 - 2030 (USD Million)
- 24. Global Pleurodynia Treatment Market by Headache, 2023 - 2030 (USD Million)
- 25. Global Pleurodynia Treatment Market by Muscular Aches & Pains, 2023 - 2030 (USD Million)
- 26. Global Pleurodynia Treatment Market share, by Region, 2023 and 2030
- 27. North America Pleurodynia Treatment Market, 2023 - 2030 (USD Million)
- 28. Europe Pleurodynia Treatment Market, 2023 - 2030 (USD Million)
- 29. Asia Pacific Pleurodynia Treatment Market, 2023 - 2030 (USD Million)
- 30. Latin America Pleurodynia Treatment Market, 2023 - 2030 (USD Million)
- 31. The Middle-East and Africa Pleurodynia Treatment Market, 2023 - 2030 (USD Million)
Table Of Tables
- 1. Global Pleurodynia Treatment Market: Snapshot
- 2. Drivers of the Pleurodynia Treatment Market: impact analysis
- 3. North America Pleurodynia Treatment Market revenue, By Causes, 2023 - 2030 (USD Million)
- 4. North America Pleurodynia Treatment Market revenue, By Complications, 2023 - 2030 (USD Million)
- 5. North America Pleurodynia Treatment Market revenue, By Symptoms, 2023 - 2030 (USD Million)
- 6. U.S. Pleurodynia Treatment Market revenue, By Causes, 2023 - 2030 (USD Million)
- 7. U.S. Pleurodynia Treatment Market revenue, By Complications, 2023 - 2030 (USD Million)
- 8. U.S. Pleurodynia Treatment Market revenue, By Symptoms, 2023 - 2030 (USD Million)
- 9. Canada Pleurodynia Treatment Market revenue, By Causes, 2023 - 2030 (USD Million)
- 10. Canada Pleurodynia Treatment Market revenue, By Complications, 2023 - 2030 (USD Million)
- 11. Canada Pleurodynia Treatment Market revenue, By Symptoms, 2023 - 2030 (USD Million)
- 12. Europe Pleurodynia Treatment Market revenue, By Causes, 2023 - 2030 (USD Million)
- 13. Europe Pleurodynia Treatment Market revenue, By Complications, 2023 - 2030 (USD Million)
- 14. Europe Pleurodynia Treatment Market revenue, By Symptoms, 2023 - 2030 (USD Million)
- 15. Germany Pleurodynia Treatment Market revenue, By Causes, 2023 - 2030 (USD Million)
- 16. Germany Pleurodynia Treatment Market revenue, By Complications, 2023 - 2030 (USD Million)
- 17. Germany Pleurodynia Treatment Market revenue, By Symptoms, 2023 - 2030 (USD Million)
- 18. France Pleurodynia Treatment Market revenue, By Causes, 2023 - 2030 (USD Million)
- 19. France Pleurodynia Treatment Market revenue, By Complications, 2023 - 2030 (USD Million)
- 20. France Pleurodynia Treatment Market revenue, By Symptoms, 2023 - 2030 (USD Million)
- 21. U.K. Pleurodynia Treatment Market revenue, By Causes, 2023 - 2030 (USD Million)
- 22. U.K. Pleurodynia Treatment Market revenue, By Complications, 2023 - 2030 (USD Million)
- 23. U.K. Pleurodynia Treatment Market revenue, By Symptoms, 2023 - 2030 (USD Million)
- 24. Italy Pleurodynia Treatment Market revenue, By Causes, 2023 - 2030 (USD Million)
- 25. Italy Pleurodynia Treatment Market revenue, By Complications, 2023 - 2030 (USD Million)
- 26. Italy Pleurodynia Treatment Market revenue, By Symptoms, 2023 - 2030 (USD Million)
- 27. Spain Pleurodynia Treatment Market revenue, By Causes, 2023 - 2030 (USD Million)
- 28. Spain Pleurodynia Treatment Market revenue, By Complications, 2023 - 2030 (USD Million)
- 29. Spain Pleurodynia Treatment Market revenue, By Symptoms, 2023 - 2030 (USD Million)
- 30. Rest of Europe Pleurodynia Treatment Market revenue, By Causes, 2023 - 2030 (USD Million)
- 31. Rest of Europe Pleurodynia Treatment Market revenue, By Complications, 2023 - 2030 (USD Million)
- 32. Rest of Europe Pleurodynia Treatment Market revenue, By Symptoms, 2023 - 2030 (USD Million)
- 33. Asia Pacific Pleurodynia Treatment Market revenue, By Causes, 2023 - 2030 (USD Million)
- 34. Asia Pacific Pleurodynia Treatment Market revenue, By Complications, 2023 - 2030 (USD Million)
- 35. Asia Pacific Pleurodynia Treatment Market revenue, By Symptoms, 2023 - 2030 (USD Million)
- 36. China Pleurodynia Treatment Market revenue, By Causes, 2023 - 2030 (USD Million)
- 37. China Pleurodynia Treatment Market revenue, By Complications, 2023 - 2030 (USD Million)
- 38. China Pleurodynia Treatment Market revenue, By Symptoms, 2023 - 2030 (USD Million)
- 39. Japan Pleurodynia Treatment Market revenue, By Causes, 2023 - 2030 (USD Million)
- 40. Japan Pleurodynia Treatment Market revenue, By Complications, 2023 - 2030 (USD Million)
- 41. Japan Pleurodynia Treatment Market revenue, By Symptoms, 2023 - 2030 (USD Million)
- 42. India Pleurodynia Treatment Market revenue, By Causes, 2023 - 2030 (USD Million)
- 43. India Pleurodynia Treatment Market revenue, By Complications, 2023 - 2030 (USD Million)
- 44. India Pleurodynia Treatment Market revenue, By Symptoms, 2023 - 2030 (USD Million)
- 45. South Korea Pleurodynia Treatment Market revenue, By Causes, 2023 - 2030 (USD Million)
- 46. South Korea Pleurodynia Treatment Market revenue, By Complications, 2023 - 2030 (USD Million)
- 47. South Korea Pleurodynia Treatment Market revenue, By Symptoms, 2023 - 2030 (USD Million)
- 48. South-East Asia Pleurodynia Treatment Market revenue, By Causes, 2023 - 2030 (USD Million)
- 49. South-East Asia Pleurodynia Treatment Market revenue, By Complications, 2023 - 2030 (USD Million)
- 50. South-East Asia Pleurodynia Treatment Market revenue, By Symptoms, 2023 - 2030 (USD Million)
- 51. Rest of Asia Pacific Pleurodynia Treatment Market revenue, By Causes, 2023 - 2030 (USD Million)
- 52. Rest of Asia Pacific Pleurodynia Treatment Market revenue, By Complications, 2023 - 2030 (USD Million)
- 53. Rest of Asia Pacific Pleurodynia Treatment Market revenue, By Symptoms, 2023 - 2030 (USD Million)
- 54. Latin America Pleurodynia Treatment Market revenue, By Causes, 2023 - 2030 (USD Million)
- 55. Latin America Pleurodynia Treatment Market revenue, By Complications, 2023 - 2030 (USD Million)
- 56. Latin America Pleurodynia Treatment Market revenue, By Symptoms, 2023 - 2030 (USD Million)
- 57. Brazil Pleurodynia Treatment Market revenue, By Causes, 2023 - 2030 (USD Million)
- 58. Brazil Pleurodynia Treatment Market revenue, By Complications, 2023 - 2030 (USD Million)
- 59. Brazil Pleurodynia Treatment Market revenue, By Symptoms, 2023 - 2030 (USD Million)
- 60. Mexico Pleurodynia Treatment Market revenue, By Causes, 2023 - 2030 (USD Million)
- 61. Mexico Pleurodynia Treatment Market revenue, By Complications, 2023 - 2030 (USD Million)
- 62. Mexico Pleurodynia Treatment Market revenue, By Symptoms, 2023 - 2030 (USD Million)
- 63. Rest of Latin America Pleurodynia Treatment Market revenue, By Causes, 2023 - 2030 (USD Million)
- 64. Rest of Latin America Pleurodynia Treatment Market revenue, By Complications, 2023 - 2030 (USD Million)
- 65. Rest of Latin America Pleurodynia Treatment Market revenue, By Symptoms, 2023 - 2030 (USD Million)
- 66. The Middle-East and Africa Pleurodynia Treatment Market revenue, By Causes, 2023 - 2030 (USD Million)
- 67. The Middle-East and Africa Pleurodynia Treatment Market revenue, By Complications, 2023 - 2030 (USD Million)
- 68. The Middle-East and Africa Pleurodynia Treatment Market revenue, By Symptoms, 2023 - 2030 (USD Million)
- 69. GCC Countries Pleurodynia Treatment Market revenue, By Causes, 2023 - 2030 (USD Million)
- 70. GCC Countries Pleurodynia Treatment Market revenue, By Complications, 2023 - 2030 (USD Million)
- 71. GCC Countries Pleurodynia Treatment Market revenue, By Symptoms, 2023 - 2030 (USD Million)
- 72. South Africa Pleurodynia Treatment Market revenue, By Causes, 2023 - 2030 (USD Million)
- 73. South Africa Pleurodynia Treatment Market revenue, By Complications, 2023 - 2030 (USD Million)
- 74. South Africa Pleurodynia Treatment Market revenue, By Symptoms, 2023 - 2030 (USD Million)
- 75. Rest of Middle-East Africa Pleurodynia Treatment Market revenue, By Causes, 2023 - 2030 (USD Million)
- 76. Rest of Middle-East Africa Pleurodynia Treatment Market revenue, By Complications, 2023 - 2030 (USD Million)
- 77. Rest of Middle-East Africa Pleurodynia Treatment Market revenue, By Symptoms, 2023 - 2030 (USD Million)
Methodology
FrequentlyAsked Questions
The global pleurodynia treatment market is projected to witness high growth owing to the increasing number of pleurodynia cases across the globe.
Pleurodynia is also known as Bornholm disease and is categorized by the occurrence of sudden and severe abdominal and chest pain.
According to study, the global pleurodynia treatment market size was worth around USD 128.57 million in 2022 and is predicted to grow to around USD 191.58 million by 2030.
The CAGR value of the pleurodynia treatment market is expected to be around 5.28% during 2023-2030.
The global pleurodynia treatment market is expected to witness the highest growth rate in North America with the US acting as the largest shareholder.
The global pleurodynia treatment market is led by players like Roche Holding AG, Gilead Sciences, AbbVie, GlaxoSmithKline, Bristol Myers Squibb, Johnson & Johnson, Boehringer Ingelheim, Pfizer, Novartis, Takeda Pharmaceuticals, Merck & Co., Bayer, Teva Pharmaceutical Industries, AstraZeneca, Amgen, Eli Lilly and Company, Sanofi, Daiichi Sankyo, and Astellas Pharma.
RelatedNews
Zion Market Research
Tel: +1 (302) 444-0166
USA/Canada Toll Free No.+1 (855) 465-4651
3rd Floor,
Mrunal Paradise, Opp Maharaja Hotel,
Pimple Gurav, Pune 411061,
Maharashtra, India
Phone No +91 7768 006 007, +91 7768 006 008
US OFFICE NO +1 (302) 444-0166
US/CAN TOLL FREE +1 (855) 465-4651
Email: sales@zionmarketresearch.com
We have secured system to process your transaction.
Our support available to help you 24 hours a day, five days a week.
Monday - Friday: 9AM - 6PM
Saturday - Sunday: Closed